LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Jeff Collins to serve as a judge for the 2nd Carolina Entrepreneurial Initiative Challenge
News | 04. 22. 2006
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.